Search for: "Hetti Hilge"
Results 1 - 7
of 7
Sorted by Relevance
|
Sort by Date
20 Mar 2020, 4:17 am
By Hetti Hilge/Dr. [read post]
31 Aug 2017, 10:44 am
Thomas MusmannIn March our partner Hetti Hilge reported on a preliminary injunction by which the Federal Patent Court granted Merck an interlocutory compulsory license for Merck’s HIV drug Isentress in the light of Shionogi’s Raltegravir patent EP 1 422 218 (link). [read post]
6 Jun 2019, 7:08 am
Thomas Musmannby Hetti Hilge In its latest FRAND judgment the Düsseldorf appeal court confirmed that in the context of FRAND evaluation the emphasis shall be – in contrast to English practice – on the ND (‘non-discriminatory’) prong of FRAND. [read post]
9 Mar 2017, 4:41 pm
Hetti Hilge, LL.M. rospatt osten pross – Intellectual Property Rechtsanwälte More from our authors: Patent Protection for Second Medical Uses by Jochen Bühling (ed.) [read post]
28 Jun 2016, 10:33 am
Hetti Hilge, LL.M. rospatt osten pross – Intellectual Property Rechtsanwälte More from our authors: Concise European Copyright Law Second Edition by Thomas Dreier, P. [read post]
18 Sep 2019, 11:05 pm
Hetti Hilge, LL.M. rospatt osten pross – Intellectual Property Rechtsanwälte More from our authors: Vissers Annotated European Patent Convention by Derk Visser, Laurence Lai, Peter de Lange, Kaisa Suominen€ 105 Japanese Patent Law: Cases and Comments by Christopher Heath, Atsuhiro Furuta€ 181 … [read post]
16 Jan 2020, 11:29 pm
As recently commented on in this blog by Hetti Hilge, a recent decision by the Karlsruhe appeals court on SEPs and FRAND highlights divergences between member state courts on key aspects of the CJEU guidance. [read post]
